The macrolide antibiotic renaissance

GP Dinos - British journal of pharmacology, 2017 - Wiley Online Library
Macrolides represent a large family of protein synthesis inhibitors of great clinical interest
due to their applicability to human medicine. Macrolides are composed of a macrocyclic …

Efflux-mediated drug resistance in bacteria: an update

XZ Li, H Nikaido - Drugs, 2009 - Springer
Drug efflux pumps play a key role in drug resistance and also serve other functions in
bacteria. There has been a growing list of multidrug and drug-specific efflux pumps …

Efflux-mediated antimicrobial resistance

K Poole - Journal of Antimicrobial Chemotherapy, 2005 - academic.oup.com
Antibiotic resistance continues to plague antimicrobial chemotherapy of infectious disease.
And while true biocide resistance is as yet unrealized, in vitro and in vivo episodes of …

Efflux pumps as antimicrobial resistance mechanisms

K Poole - Annals of medicine, 2007 - Taylor & Francis
Antibiotic resistance continues to hamper antimicrobial chemotherapy of infectious disease,
and while biocide resistance outside of the laboratory is as yet unrealized, in vitro and in …

Resistance to macrolide antibiotics in public health pathogens

C Fyfe, TH Grossman… - Cold Spring …, 2016 - perspectivesinmedicine.cshlp.org
Macrolide resistance mechanisms can be target-based with a change in a 23S ribosomal
RNA (rRNA) residue or a mutation in ribosomal protein L4 or L22 affecting the ribosome's …

Multidrug Efflux Pumps from Enterobacteriaceae, Vibrio cholerae and Staphylococcus aureus Bacterial Food Pathogens

JL Andersen, GX He, P Kakarla, R Kc, S Kumar… - International journal of …, 2015 - mdpi.com
Foodborne illnesses caused by bacterial microorganisms are common worldwide and
constitute a serious public health concern. In particular, microorganisms belonging to the …

Macrolide resistance mechanisms in Enterobacteriaceae: Focus on azithromycin

C Gomes, S Martínez-Puchol, N Palma… - Critical reviews in …, 2017 - Taylor & Francis
From its introduction in 1952 onwards, the clinical use of macrolides has been steadily
increasing, both in human and veterinary medicine. Although initially designed to the …

[HTML][HTML] Escherichia coli as reservoir for macrolide resistance genes

MCP Nguyen, PL Woerther, M Bouvet… - Emerging infectious …, 2009 - ncbi.nlm.nih.gov
The plasmid-borne mph (A) gene that confers resistance to azithromycin and has recently
emerged in Shigella sonnei is present in multidrug-and non–multidrug-resistant Escherichia …

Azithromycin resistance levels and mechanisms in Escherichia coli

C Gomes, L Ruiz-Roldán, J Mateu, TJ Ochoa, J Ruiz - Scientific reports, 2019 - nature.com
Despite azithromycin being used in some countries to treat infections caused by Gram-
negative pathogens, no resistance breakpoint for Escherichia coli exists. The aim of this …

Antimicrobial resistance, multilocus sequence types and virulence profiles of ESBL producing and non-ESBL producing uropathogenic Escherichia coli isolated from …

AL Zogg, K Zurfluh, S Schmitt… - Veterinary …, 2018 - Elsevier
Among 64 uropathogenic Escherichia coli (UPEC) isolated from 13 cats and 51 dogs, 35
were extended-spectrum beta-lactamase (ESBL) producers, and 29 were non-ESBL …